An update of novel screening methods for GPCR in drug discovery

Bibliography

• Vassilatis DK, Hohmann JG, Zeng H, The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA 2003;100(8):4903-8
   PubMed Web of Science ®Google Scholar
• Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 2003;63(6):1256-72
   PubMed Web of Science ®Google Scholar
• Gloriam DE, Fredriksson R, Schioth HB. The G protein-coupled receptor subset of the rat genome. BMC Genomics 2007;8:338
   PubMedGoogle Scholar
• Russ AP, Lampel S. The druggable genome: an update. Drug Discov Today 2005;10(23-24):1607-10
   PubMed Web of Science ®Google Scholar
• Shenoy SK, Drake MT, Nelson CD, beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem 2006;281(2):1261-73
   PubMed Web of Science ®Google Scholar
• Shukla AK, Xiao K, Lefkowitz RJ. Emerging paradigms of beta-arrestin-dependent seven transmembrane receptor signaling. Trends Biochem Sci 2011;36(9):457-69
   PubMed Web of Science ®Google Scholar
• Hern JA, Baig AH, Mashanov GI, Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules. Proc Natl Acad Sci USA 2010;107(6):2693-8
   PubMed Web of Science ®Google Scholar
• Liu XY, Liu ZC, Sun YG, Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell 2011;147(2):447-58
   PubMed Web of Science ®Google Scholar
• Fribourg M, Moreno JL, Holloway T, Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs. Cell 2011;147(5):1011-23
   PubMed Web of Science ®Google Scholar
• Whalen EJ, Rajagopal S, Lefkowitz RJ. Therapeutic potential of beta-arrestin- and G protein-biased agonists. Trends Mol Med 2011;17(3):126-39
   PubMed Web of Science ®Google Scholar
• Ferre S, Lluis C, Lanciego JL, Franco R. Prime time for G-protein-coupled receptor heteromers as therapeutic targets for CNS disorders: the dopamine D-D receptor heteromer. CNS Neurol Disord Drug Targets 2010;9(5):596-600
   PubMed Web of Science ®Google Scholar
• Smith NJ, Milligan G. Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol Rev 2010;62(4):701-25
   PubMed Web of Science ®Google Scholar
• Lefkowitz RJ, Roth J, Pricer W, Pastan I. ACTH receptors in the adrenal: specific binding of ACTH-125I and its relation to adenyl cyclase. Proc Natl Acad Sci USA 1970;65(3):745-52
   PubMed Web of Science ®Google Scholar
• Lefkowitz RJ, Roth J, Pastan I. Effects of calcium on ACTH stimulation of the adrenal: separation of hormone binding from adenyl cyclase activation. Nature 1970;228(5274):864-6
   PubMed Web of Science ®Google Scholar
• Lefkowitz RJ, Roth J, Pastan I. Radioreceptor assay of adrenocorticotropic hormone: new approach to assay of polypeptide hormones in plasma. Science 1970;170(3958):633-5
   PubMed Web of Science ®Google Scholar
• Udenfriend S, Gerber L, Nelson N. Scintillation proximity assay: a sensitive and continuous isotopic method for monitoring ligand/receptor and antigen/antibody interactions. Anal Biochem 1987;161(2):494-500
   PubMed Web of Science ®Google Scholar
• Glickman JF, Schmid A, Ferrand S. Scintillation proximity assays in high-throughput screening. Assay Drug Dev Technol 2008;6(3):433-55
   PubMed Web of Science ®Google Scholar
• Daly CJ, Ross RA, Whyte J, Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-like' receptors in small arteries. Br J Pharmacol 2010;159(4):787-96
   PubMed Web of Science ®Google Scholar
• Banks P, Gosselin M, Prystay L. Impact of a red-shifted dye label for high throughput fluorescence polarization assays of G protein-coupled receptors. J Biomol Screen 2000;5(5):329-34
   PubMed Web of Science ®Google Scholar
• Turek-Etienne TC, Lei M, Terracciano JS, Use of red-shifted dyes in a fluorescence polarization AKT kinase assay for detection of biological activity in natural product extracts. J Biomol Screen 2004;9(1):52-61
   PubMed Web of Science ®Google Scholar
• Vazquez ME, Blanco JB, Salvadori S, 6-N,N-dimethylamino-2,3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides. J Med Chem 2006;49(12):3653-8
   PubMed Web of Science ®Google Scholar
• Fichter KM, Flajolet M, Greengard P, Vu TQ. Kinetics of G-protein-coupled receptor endosomal trafficking pathways revealed by single quantum dots. Proc Natl Acad Sci USA 2010;107(43):18658-63
   PubMed Web of Science ®Google Scholar
• Middleton RJ, Kellam B. Fluorophore-tagged GPCR ligands. Curr Opin Chem Biol 2005;9(5):517-25
   PubMed Web of Science ®Google Scholar
• Burke TJ, Loniello KR, Beebe JA, Ervin KM. Development and application of fluorescence polarization assays in drug discovery. Comb Chem High Throughput Screen 2003;6(3):183-94
   PubMed Web of Science ®Google Scholar
• Lea WA, Simeonov A. Fluorescence polarization assays in small molecule screening. Expert Opin Drug Discov 2011;6(1):17-32
   PubMed Web of Science ®Google Scholar
• Gradinaru CC, Marushchak DO, Samim M, Krull UJ. Fluorescence anisotropy: from single molecules to live cells. Analyst 2010;135(3):452-9
   PubMed Web of Science ®Google Scholar
• Jameson DM, Ross JA. Fluorescence polarization/anisotropy in diagnostics and imaging. Chem Rev 2010;110(5):2685-708
   PubMed Web of Science ®Google Scholar
• Harikumar KG, Cawston EE, Miller LJ. Fluorescence polarization screening for allosteric small molecule ligands of the cholecystokinin receptor. Assay Drug Dev Technol 2011;9(4):394-402
   PubMed Web of Science ®Google Scholar
• Kecskes M, Kumar TS, Yoo L, Novel alexa fluor-488 labeled antagonist of the A(2A) adenosine receptor: application to a fluorescence polarization-based receptor binding assay. Biochem Pharmacol 2010;80(4):506-11
   PubMed Web of Science ®Google Scholar
• Bazin H, Trinquet E, Mathis G. Time resolved amplification of cryptate emission: a versatile technology to trace biomolecular interactions. J Biotechnol 2002;82(3):233-50
   PubMedGoogle Scholar
• Keppler A, Gendreizig S, Gronemeyer T, A general method for the covalent labeling of fusion proteins with small molecules in vivo. Nat Biotechnol 2003;21(1):86-9
   PubMed Web of Science ®Google Scholar
• Gautier A, Juillerat A, Heinis C, An engineered protein tag for multiprotein labeling in living cells. Chem Biol 2008;15(2):128-36
   PubMed Web of Science ®Google Scholar
• Los GV, Encell LP, McDougall MG, HaloTag: a novel protein labeling technology for cell imaging and protein analysis. ACS Chem Biol 2008;3(6):373-82
   PubMed Web of Science ®Google Scholar
• Zwier JM, Roux T, Cottet M, A fluorescent ligand-binding alternative using Tag-lite(R) technology. J Biomol Screen 2010;15(10):1248-59
   PubMed Web of Science ®Google Scholar
• Dimond P, Carlson K, Bouvier M, G protein-coupled receptor modulation with pepducins: moving closer to the clinic. Ann NY Acad Sci 2011;1226:34-49
   PubMed Web of Science ®Google Scholar
• De Amici M, Dallanoce C, Holzgrabe U, Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities. Med Res Rev 2010;30(3):463-549
   PubMed Web of Science ®Google Scholar
• Grigoriadis DE, Hoare SR, Lechner SM, Druggability of extracellular targets: discovery of small molecule drugs targeting allosteric, functional, and subunit-selective sites on GPCRs and ion channels. Neuropsychopharmacology 2009;34(1):106-25
   PubMed Web of Science ®Google Scholar
• Wang L, Martin B, Brenneman R, Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders. J Pharmacol Exp Ther 2009;331(2):340-8
   PubMed Web of Science ®Google Scholar
• Navratilova I, Hopkins AL. Emerging role of surface plasmon resonance in fragment-based drug discovery. Future Med Chem 2011;3(14):1809-20
   PubMed Web of Science ®Google Scholar
• Navratilova I, Besnard J, Hopkins AL. Screening for GPCR ligands using surface plasmon resonance. ACS Med Chem Lett 2011;2(7):549-54
   PubMed Web of Science ®Google Scholar
• Congreve M, Rich RL, Myszka DG, Fragment screening of stabilized G-protein-coupled receptors using biophysical methods. Methods Enzymol 2011;493:115-36
   PubMed Web of Science ®Google Scholar
• Ferrer M, Kolodin GD, Zuck P, A fully automated [35S]GTPgammaS scintillation proximity assay for the high-throughput screening of Gi-linked G protein-coupled receptors. Assay Drug Dev Technol 2003;1(2):261-73
   PubMed Web of Science ®Google Scholar
• Johnson EN, Shi X, Cassaday J, A 1,536-well [(35)S]GTPgammaS scintillation proximity binding assay for ultra-high-throughput screening of an orphan galphai-coupled GPCR. Assay Drug Dev Technol 2008;6(3):327-37
   PubMed Web of Science ®Google Scholar
• Koval A, Kopein D, Purvanov V, Katanaev VL. Europium-labeled GTP as a general nonradioactive substitute for [(35)S]GTPgammaS in high-throughput G protein studies. Anal Biochem 2010;397(2):202-7
   PubMed Web of Science ®Google Scholar
• Labrecque J, Wong RS, Fricker SP. A time-resolved fluorescent lanthanide (Eu)-GTP binding assay for chemokine receptors as targets in drug discovery. Methods Mol Biol 2009;552:153-69
   PubMedGoogle Scholar
• Eglen RM, Reisine T. Photoproteins: important new tools in drug discovery. Assay Drug Dev Technol 2008;6(5):659-71
   PubMed Web of Science ®Google Scholar
• Bovolenta S, Foti M, Lohmer S, Corazza S. Development of a Ca(2+)-activated photoprotein, Photina, and its application to high-throughput screening. J Biomol Screen 2007;12(5):694-704
   PubMed Web of Science ®Google Scholar
• Laptenok SP, van Stokkum IH, Borst JW, Disentangling picosecond events that complicate the quantitative use of the calcium sensor YC3.60. J Phys Chem B 2012;116(9):3013-20
   PubMed Web of Science ®Google Scholar
• Charlton SJ, Vauquelin G. Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays. Br J Pharmacol 2010;161(6):1250-65
   PubMed Web of Science ®Google Scholar
• Brandish PE, Hill LA, Zheng W, Scolnick EM. Scintillation proximity assay of inositol phosphates in cell extracts: high-throughput measurement of G-protein-coupled receptor activation. Anal Biochem 2003;313(2):311-18
   PubMed Web of Science ®Google Scholar
• Trinquet E, Fink M, Bazin H, D-myo-inositol 1-phosphate as a surrogate of D-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation. Anal Biochem 2006;358(1):126-35
   PubMed Web of Science ®Google Scholar
• Bergsdorf C, Kropp-Goerkis C, Kaehler I, A one-day, dispense-only IP-One HTRF assay for high-throughput screening of galphaq protein-coupled receptors: towards cells as reagents. Assay Drug Dev Technol 2008;6(1):39-53
   PubMed Web of Science ®Google Scholar
• Liu K, Titus S, Southall N, Comparison on functional assays for Gq-coupled GPCRs by measuring inositol monophospate-1 and intracellular calcium in 1536-well plate format. Curr Chem Genomics 2008;1:70-8
   PubMedGoogle Scholar
• Trinquet E, Bouhelal R, Dietz M. Monitoring Gq-coupled receptor response through inositol phosphate quantification with the IP-One assay. Expert Opin Drug Discov 2011;6(10):981-94
   PubMed Web of Science ®Google Scholar
• Reinscheid RK, Kim J, Zeng J, Civelli O. High-throughput real-time monitoring of Gs-coupled receptor activation in intact cells using cyclic nucleotide-gated channels. Eur J Pharmacol 2003;478(1):27-34
   PubMed Web of Science ®Google Scholar
• Visegrady A, Boros A, Nemethy Z, Application of the BD ACTOne technology for the high-throughput screening of Gs-coupled receptor antagonists. J Biomol Screen 2007;12(8):1068-73
   PubMed Web of Science ®Google Scholar
• Pantel J, Williams SY, Mi D, Development of a high throughput screen for allosteric modulators of melanocortin-4 receptor signaling using a real time cAMP assay. Eur J Pharmacol 2011;660(1):139-47
   PubMed Web of Science ®Google Scholar
• Buccioni M, Marucci G, Dal Ben D, Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17. Purinergic Signal 2011;7(4):463-8
   PubMed Web of Science ®Google Scholar
• Nikolaev VO, Bunemann M, Hein L, Novel single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem 2004;279(36):37215-18
   PubMed Web of Science ®Google Scholar
• Fan F, Binkowski BF, Butler BL, Novel genetically encoded biosensors using firefly luciferase. ACS Chem Biol 2008;3(6):346-51
   PubMed Web of Science ®Google Scholar
• Reversi A, Rimoldi V, Marrocco T, The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism. J Biol Chem 2005;280(16):16311-18
   PubMed Web of Science ®Google Scholar
• Buch TR, Heling D, Damm E, Pertussis toxin-sensitive signaling of melanocortin-4 receptors in hypothalamic GT1-7 cells defines agouti-related protein as a biased agonist. J Biol Chem 2009;284(39):26411-20
   PubMed Web of Science ®Google Scholar
• Azzi M, Charest PG, Angers S, Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci USA 2003;100(20):11406-11
   PubMed Web of Science ®Google Scholar
• Rajagopal S, Rajagopal K, Lefkowitz RJ. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 2010;9(5):373-86
   PubMed Web of Science ®Google Scholar
• Gesty-Palmer D, Flannery P, Yuan L, A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci Transl Med 2009;1(1):1ra1
   PubMed Web of Science ®Google Scholar
• Stallaert W, Christopoulos A, Bouvier M. Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors. Expert Opin Drug Discov 2011;6(8):811-25
   PubMed Web of Science ®Google Scholar
• Galandrin S, Oligny-Longpre G, Bouvier M. The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol Sci 2007;28(8):423-30
   PubMed Web of Science ®Google Scholar
• Vaidehi N, Kenakin T. The role of conformational ensembles of seven transmembrane receptors in functional selectivity. Curr Opin Pharmacol 2010;10(6):775-81
   PubMed Web of Science ®Google Scholar
• Marshall FH, Foord SM. Heterodimerization of the GABAB receptor-implications for GPCR signaling and drug discovery. Adv Pharmacol 2010;58:63-91
   PubMedGoogle Scholar
• Albizu L, Moreno JL, Gonzalez-Maeso J, Sealfon SC. Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics. CNS Neurol Disord Drug Targets 2010;9(5):636-50
   PubMed Web of Science ®Google Scholar
• Marchese A, Paing MM, Temple BR, Trejo J. G protein-coupled receptor sorting to endosomes and lysosomes. Annu Rev Pharmacol Toxicol 2008;48:601-29
   PubMed Web of Science ®Google Scholar
• Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science 2005;308(5721):512-17
   PubMed Web of Science ®Google Scholar
• Richman JG, Kanemitsu-Parks M, Gaidarov I, Nicotinic acid receptor agonists differentially activate downstream effectors. J Biol Chem 2007;282(25):18028-36
   PubMed Web of Science ®Google Scholar
• Bertrand L, Parent S, Caron M, The BRET2/arrestin assay in stable recombinant cells: a platform to screen for compounds that interact with G protein-coupled receptors (GPCRS). J Recept Signal Transduct Res 2002;22(1-4):533-41
   PubMed Web of Science ®Google Scholar
• Hamdan FF, Audet M, Garneau P, High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay. J Biomol Screen 2005;10(5):463-75
   PubMed Web of Science ®Google Scholar
• Kamal M, Marquez M, Vauthier V, Improved donor/acceptor BRET couples for monitoring beta-arrestin recruitment to G protein-coupled receptors. Biotechnol J 2009;4(9):1337-44
   PubMedGoogle Scholar
• Vrecl M, Jorgensen R, Pogacnik A, Heding A. Development of a BRET2 screening assay using beta-arrestin 2 mutants. J Biomol Screen 2004;9(4):322-33
   PubMed Web of Science ®Google Scholar
• Qiu Y, Loh HH, Law PY. Phosphorylation of the delta-opioid receptor regulates its beta-arrestins selectivity and subsequent receptor internalization and adenylyl cyclase desensitization. J Biol Chem 2007;282(31):22315-23
   PubMed Web of Science ®Google Scholar
• Klewe IV, Nielsen SM, Tarpo L, Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling. Neuropharmacology 2008;54(8):1215-22
   PubMed Web of Science ®Google Scholar
• Masri B, Salahpour A, Didriksen M, Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics. Proc Natl Acad Sci USA 2008;105(36):13656-61
   PubMed Web of Science ®Google Scholar
• Leduc M, Breton B, Gales C, Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands. J Pharmacol Exp Ther 2009;331(1):297-307
   PubMed Web of Science ®Google Scholar
• Olson KR, Eglen RM. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol 2007;5(1):137-44
   PubMed Web of Science ®Google Scholar
• van Der Lee MM, Bras M, van Koppen CJ, Zaman GJ. Beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1. J Biomol Screen 2008;13(10):986-98
   PubMed Web of Science ®Google Scholar
• Yin H, Chu A, Li W, Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem 2009;284(18):12328-38
   PubMed Web of Science ®Google Scholar
• Barnea G, Strapps W, Herrada G, The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci USA 2008;105(1):64-9
   PubMed Web of Science ®Google Scholar
• Wetter JA, Revankar C, Hanson BJ. Utilization of the tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation. J Biomol Screen 2009;14(9):1134-41
   PubMed Web of Science ®Google Scholar
• Doucette C, Vedvik K, Koepnick E, Kappa opioid receptor screen with the Tango beta-arrestin recruitment technology and characterization of hits with second-messenger assays. J Biomol Screen 2009;14(4):381-94
   PubMed Web of Science ®Google Scholar
• Allen JA, Yost JM, Setola V, Discovery of beta-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc Natl Acad Sci USA 2011;108(45):18488-93
   PubMed Web of Science ®Google Scholar
• Djannatian MS, Galinski S, Fischer TM, Rossner MJ. Studying G protein-coupled receptor activation using split-tobacco etch virus assays. Anal Biochem 2011;412(2):141-52
   PubMed Web of Science ®Google Scholar
• Wehr MC, Laage R, Bolz U, Monitoring regulated protein-protein interactions using split TEV. Nat Methods 2006;3(12):985-93
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang W, Chen L, Development of a novel DnaE intein-based assay for quantitative analysis of G-protein-coupled receptor internalization. Anal Biochem 2011;417(1):65-72
   PubMed Web of Science ®Google Scholar
• Iwai H, Zuger S, Jin J, Tam PH. Highly efficient protein trans-splicing by a naturally split DnaE intein from Nostoc punctiforme. FEBS Lett 2006;580(7):1853-8
   PubMed Web of Science ®Google Scholar
• Kim SB, Ozawa T, Watanabe S, Umezawa Y. High-throughput sensing and noninvasive imaging of protein nuclear transport by using reconstitution of split Renilla luciferase. Proc Natl Acad Sci USA 2004;101(32):11542-7
   PubMed Web of Science ®Google Scholar
• Kwon YJ, Lee W, Genovesio A, Emans N. A high-content subtractive screen for selecting small molecules affecting internalization of GPCRs. J Biomol Screen 2012;17(3):379-85
   PubMed Web of Science ®Google Scholar
• Kredel S, Wolff M, Hobbie S, High-content analysis of CCR2 antagonists on human primary monocytes. J Biomol Screen 2011;16(7):683-93
   PubMed Web of Science ®Google Scholar
• Ross DA, Lee S, Reiser V, Multiplexed assays by high-content imaging for assessment of GPCR activity. J Biomol Screen 2008;13(6):449-55
   PubMed Web of Science ®Google Scholar
• Takeda Y, Yano Y, Matsuzaki K. High-throughput analysis of ligand-induced internalization of beta2-adrenoceptors using the coiled-coil tag-probe method. Anal Chem 2012;84(3):1754-9
   PubMed Web of Science ®Google Scholar
• Thomas N. High-content screening: a decade of evolution. J Biomol Screen 2010;15(1):1-9
   PubMed Web of Science ®Google Scholar
• Siehler S. Cell-based assays in GPCR drug discovery. Biotechnol J 2008;3(4):471-83
   PubMedGoogle Scholar
• Munos B. Lessons from 60 years of pharmaceutical innovation. Nat Rev Drug Discov 2009;8(12):959-68
   PubMed Web of Science ®Google Scholar
• Swinney DC, Anthony J. How were new medicines discovered? Nat Rev Drug Discov 2011;10(7):507-19
   PubMed Web of Science ®Google Scholar
• Roth BL, Sheffler DJ, Kroeze WK. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 2004;3(4):353-9
   PubMed Web of Science ®Google Scholar
• Graminski GF, Jayawickreme CK, Potenza MN, Lerner MR. Pigment dispersion in frog melanophores can be induced by a phorbol ester or stimulation of a recombinant receptor that activates phospholipase C. J Biol Chem 1993;268(8):5957-64
   PubMed Web of Science ®Google Scholar
• Peters MF, Scott CW. Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity. J Biomol Screen 2009;14(3):246-55
   PubMed Web of Science ®Google Scholar
• Stallaert W, Dorn JF, Westhuizen E, Impedance responses reveal beta-adrenergic receptor signaling pluridimensionality and allow classification of ligands with distinct signaling profiles. PLoS One 2012;7(1):e29420
   PubMedGoogle Scholar
• Eglen R, Reisine T. Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening. Assay Drug Dev Technol 2011;9(2):108-24
   PubMed Web of Science ®Google Scholar
• Eglen RM, Gilchrist A, Reisine T. The use of immortalized cell lines in GPCR screening: the good, bad and ugly. Comb Chem High Throughput Screen 2008;11(7):560-5
   PubMed Web of Science ®Google Scholar
• Halai R, Cooper MA. Using label-free screening technology to improve efficiency in drug discovery. Expert Opin Drug Discov 2012;7(2):123-31
   PubMed Web of Science ®Google Scholar
• Fang Y. The development of label-free cellular assays for drug discovery. Expert Opin Drug Discov 2011;6(12):1285-98
   PubMed Web of Science ®Google Scholar
• Miller J, Agarwal A, Devi LA, Insider access: pepducin symposium explores a new approach to GPCR modulation. Ann NY Acad Sci 2009;1180(Suppl 1):E1-12
   PubMedGoogle Scholar
• Janz JM, Ren Y, Looby R, Direct interaction between an allosteric agonist pepducin and the chemokine receptor CXCR4. J Am Chem Soc 2011;133(40):15878-81
   PubMed Web of Science ®Google Scholar